David Gionco Insider Trading $SVNT SAVIENT PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for David Gionco.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of David Gionco. David Gionco is Group Vice President, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and Group VP & CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and Group VP, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and VP, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and Chief Accounting Officer in STEMLINE THERAPEUTICS INC ($STML).

Over the past year David Gionco has been an insider in 1 company. The total value of shares held by David Gionco in this company amounts to $1,397,902.

David Gionco Group Vice President, CFO, Group VP & CFO, Group VP, CFO
SAVIENT PHARMACEUTICALS INC
Chief Accounting Officer
STEMLINE THERAPEUTICS INC
$ 1397902 The total value of shares held by David Gionco
Insider Rank

David Gionco ranks 14,800 out of 350,000 insiders. Go to Insider Ranking to see more.

David Gionco in SAVIENT PHARMACEUTICALS INC

Trading Symbol: SVNT
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of David Gionco: Group Vice President, CFO, Group VP & CFO, Group VP, CFO
Holdings: 42,735 shares
Current Value: $2,008,545
Latest Transaction: Jan 27 2011
$SVNT Market Capitalization: $1.02B
$SVNT Previous Close: $47.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of David Gionco in SAVIENT PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, SVNT, STML

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 27 2011SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOSellS10.002,03220,32042,73544.8 K to 42.7 K (-4.54 %)
Jan 27 2011SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOGrantA10.037373244,76744.7 K to 44.8 K (+0.16 %)
Jan 27 2011SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOGrantA11.956071744,69444.6 K to 44.7 K (+0.13 %)
Jan 27 2011SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOGrantA10.237172744,63444.6 K to 44.6 K (+0.16 %)
Jan 27 2011SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOGrantA11.451441,64944,56344.4 K to 44.6 K (+0.32 %)
Dec 30 2010SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOSellS11.871,53618,23344,41946 K to 44.4 K (-3.34 %)
Sep 20 2010SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup Vice Presiden ...Payment of ExerciseF20.278,118164,55245,95554.1 K to 46 K (-15.01 %)
Sep 20 2010SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup Vice Presiden ...GrantA20.2722,918464,54854,07331.2 K to 54.1 K (+73.56 %)
Feb 17 2010SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOSellS13.811,25317,30031,15532.4 K to 31.2 K (-3.87 %)
Feb 11 2010SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOSellS12.772,03726,00332,40834.4 K to 32.4 K (-5.91 %)
Dec 22 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidVP, CFOSellS12.951,51119,56134,44536 K to 34.4 K (-4.20 %)
Dec 22 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidVP, CFOGrantA11.356169235,95635.9 K to 36 K (+0.17 %)
Sep 15 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP, CFOOption ExerciseM4.327,50032,4000
Sep 15 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP, CFOSellS15.957,500119,62535,89543.4 K to 35.9 K (-17.28 %)
Sep 15 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP, CFOBuyM4.327,50032,40043,39535.9 K to 43.4 K (+20.89 %)
Sep 15 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP, CFOSellS15.3610,887167,22435,89546.8 K to 35.9 K (-23.27 %)
Sep 15 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP, CFOGrantA11.356270446,78246.7 K to 46.8 K (+0.13 %)
Sep 15 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP, CFOGrantA5.4012969646,72046.6 K to 46.7 K (+0.28 %)
Sep 15 2009SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP, CFOGrantA3.673771,38446,59146.2 K to 46.6 K (+0.82 %)

Page:   1